Drug startup has closed on $2.5 million in new financing.

Medtronic, a medical technology company based in Minnesota, made the investment. It pledged to invest $7.5 million in NanoCor two years ago.

NanoCor is developing a treatment for congestive heart failure. It is utilizing technology developed at UNC-Chapel Hill.